AI for Diabetic Eye Disease Screening South Africa: Recall and Patient Education at Scale
Diabetic Eye Disease: South Africa's Silent Vision Crisis
South Africa has one of the highest diabetes prevalence rates in Sub-Saharan Africa, with an estimated 4.5 million people living with diabetes. Diabetic retinopathy is the leading cause of preventable blindness in working-age adults — and it is almost entirely preventable with annual retinal screening and appropriate management. Yet most South African diabetic patients do not receive annual retinal screening because no systematic recall system reaches them.
AI for diabetic eye disease screening in South Africa addresses this gap — systematically recalling diabetic patients for their annual retinal screening and educating them about the importance of eye care as part of diabetes management.
How AI Supports Diabetic Eye Screening Programmes
Annual Diabetic Screening Recall
Optometry practices offering diabetic retinal screening can configure Xtreme AI to identify diabetic patients in their system and send annual screening recall messages at the correct interval. These messages highlight the importance of annual eye screening for diabetic patients, creating genuine motivation to attend.
Patient Education Messaging
AI can send educational WhatsApp messages to diabetic patients between screening appointments — covering topics such as how diabetes affects the eyes, what symptoms warrant urgent attention, and how blood sugar control relates to eye health. This positions the practice as a trusted diabetes eye care partner, not just a routine screening provider.
GP and Endocrinologist Referral Network Communication
Optometry practices offering diabetic screening can use AI to communicate with referring GPs and endocrinologists — sending automated acknowledgement messages when referred patients complete their screening, and flagging urgent findings for immediate medical attention.
Frequently Asked Questions
Does AI work for optometrists using retinal cameras or OCT technology?
Yes. Xtreme AI manages the patient communication aspects of diabetic screening regardless of the imaging technology used. The AI schedules recall, manages patient communication, and sends results summaries to patients and referring practitioners.
Can AI target newly diagnosed diabetic patients in the practice's patient base?
Yes. If your practice management system flags new diabetes diagnoses (recorded with patient consent), AI can trigger a targeted diabetic screening recall sequence for newly identified diabetic patients.
Build a diabetic eye screening programme that reaches every patient who needs it. Book a free demo with Xtreme AI.
